Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-021419
Filing Date
2012-04-03
Accepted
2012-04-03 16:39:35
Documents
1
Period of Report
2012-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3071
  Complete submission text file 0001209191-12-021419.txt   4433
Mailing Address 175 TOYOTA PLAZA 7TH FLOOR MEMPHIS TN 38103
Business Address 175 TOYOTA PLAZA 7TH FLOOR MEMPHIS TN 38103 901-523-9700
GTX INC /DE/ (Issuer) CIK: 0001260990 (see all company filings)

EIN.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CANCER VAX CORP 2110 RUTHERFORD ROAD CARLSBAD CA 92008
Business Address
CARTER MICHAEL G (Reporting) CIK: 0001265793 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50549 | Film No.: 12738206